Y201 20mg Pill — YELLOW CAPSULE, 14mm — Duloxetine

Y201 pill photo
View full Duloxetine profile
ImprintY201 / 20mg
ColourYELLOW
ShapeCAPSULE
Size14
StrengthDULOXETINE HYDROCHLORIDE 20 mg
Dosage formCapsule, Delayed Release Pellets
ManufacturerYaopharma Co., Ltd.
NDC50771-201
Schedule—
AvailabilityPrescription only
IngredientsDULOXETINE HYDROCHLORIDE[DULOXETINE]

What does this imprint mean?

The imprint "Y201 20mg" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Duloxetine

Uses and warnings

BOXED WARNING: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is essential during treatment initiation and dose changes. Key Precautions Include: - Hepatotoxicity: Risk of liver failure; avoid in chronic liver disease or cirrhosis - Orthostatic Hypotension & Falls: May cause blood pressure drops and syncope, particularly in elderly patients - Serotonin Syndrome: Dangerous interaction risk with MAOIs and other serotonergic drugs - Abnormal Bleeding: Increased bleeding risk, especially with NSAIDs or anticoagulants - Discontinuation Symptoms: Gradual dose reduction recommended to avoid dizziness, headache, nausea - Severe Skin Reactions: Stevens-Johnson Syndrome possible; discontinue at first sign - Angle-Closure Glaucoma: May trigger attacks in susceptible patients - Blood Pressure Monitoring: Required before and during treatment ---

Duloxetine delayed-release capsules are indicated for treating: "Major Depressive Disorder (MDD)," "Generalized Anxiety Disorder (GAD)," "Diabetic Peripheral Neuropathy," and "Chronic Musculoskeletal Pain." ---

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Duloxetine

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 90224073-178e-7ec5-e053-2995a90a20fc.xml